Helical β-peptide inhibitors of the p53-hDM2 interaction JA Kritzer, JD Lear, ME Hodsdon, A Schepartz Journal of the American Chemical Society 126 (31), 9468-9469, 2004 | 384 | 2004 |
The ecstasy and agony of assay interference compounds C Aldrich, C Bertozzi, GI Georg, L Kiessling, C Lindsley, D Liotta, ... ACS Chemical Neuroscience 8 (3), 420-423, 2017 | 285 | 2017 |
High-resolution structure of a β-peptide bundle DS Daniels, EJ Petersson, JX Qiu, A Schepartz Journal of the American Chemical Society 129 (6), 1532-1533, 2007 | 245 | 2007 |
β-Peptides as inhibitors of protein–protein interactions JA Kritzer, OM Stephens, DA Guarracino, SK Reznik, A Schepartz Bioorganic & medicinal chemistry 13 (1), 11-16, 2005 | 234 | 2005 |
Inhibiting HIV fusion with a β-peptide foldamer OM Stephens, S Kim, BD Welch, ME Hodsdon, MS Kay, A Schepartz Journal of the American Chemical Society 127 (38), 13126-13127, 2005 | 226 | 2005 |
Two-colour live-cell nanoscale imaging of intracellular targets F Bottanelli, EB Kromann, ES Allgeyer, RS Erdmann, S Wood Baguley, ... Nature communications 7 (1), 10778, 2016 | 212 | 2016 |
Selective recognition of protein tetraserine motifs with a cell-permeable, pro-fluorescent bis-boronic acid TL Halo, J Appelbaum, EM Hobert, DM Balkin, A Schepartz Journal of the American Chemical Society 131 (2), 438-439, 2009 | 212 | 2009 |
Arginine topology controls escape of minimally cationic proteins from early endosomes to the cytoplasm JS Appelbaum, JR LaRochelle, BA Smith, DM Balkin, JM Holub, ... Chemistry & biology 19 (7), 819-830, 2012 | 205 | 2012 |
Mechanism of DNA-binding enhancement by the human T-cell leukaemia virus transactivator Tax AM Baranger, CR Palmer, MK Hamm, HA Giebler, A Brauweiler, ... Nature 376 (6541), 606-608, 1995 | 205 | 1995 |
Conformation-dependent cleavage of staphylococcal nuclease with a disulfide-linked iron chelate. MR Ermacora, JM Delfino, B Cuenoud, A Schepartz, RO Fox Proceedings of the National Academy of Sciences 89 (14), 6383-6387, 1992 | 191 | 1992 |
Structure of the bacterial ribosome at 2 Å resolution ZL Watson, FR Ward, R Méheust, O Ad, A Schepartz, JF Banfield, ... elife 9, e60482, 2020 | 190 | 2020 |
Altered specificity of DNA-binding proteins with transition metal dimerization domains B Cuenoud, A Schepartz Science 259 (5094), 510-513, 1993 | 180 | 1993 |
Sophistication of foldamer form and function in vitro and in vivo AD Bautista, CJ Craig, EA Harker, A Schepartz Current Opinion in Chemical Biology 11 (6), 685-692, 2007 | 174 | 2007 |
Long time-lapse nanoscopy with spontaneously blinking membrane probes H Takakura, Y Zhang, RS Erdmann, AD Thompson, Y Lin, B McNellis, ... Nature biotechnology 35 (8), 773-780, 2017 | 173 | 2017 |
Highly specific DNA recognition by a designed miniature protein NJ Zondlo, A Schepartz Journal of the American Chemical Society 121 (29), 6938-6939, 1999 | 169 | 1999 |
Surveying polypeptide and protein domain conformation and association with FlAsH and ReAsH NW Luedtke, RJ Dexter, DB Fried, A Schepartz Nature chemical biology 3 (12), 779-784, 2007 | 167 | 2007 |
Helix Macrodipole Control of β3-Peptide 14-Helix Stability in Water SA Hart, ABF Bahadoor, EE Matthews, XJ Qiu, A Schepartz Journal of the American Chemical Society 125 (14), 4022-4023, 2003 | 162 | 2003 |
Site-specific cleavage of the protein calmodulin using a trifluoperazine-based affinity reagent A Schepartz, B Cuenoud Journal of the American Chemical Society 112 (8), 3247-3249, 1990 | 161 | 1990 |
Design and evolution of a miniature Bcl‐2 binding protein JW Chin, A Schepartz Angewandte Chemie 113 (20), 3922-3925, 2001 | 159 | 2001 |
Kinetic studies of fos⊙ jun⊙ DNA complex formation: DNA binding prior to dimerization JJ Kohler, A Schepartz Biochemistry 40 (1), 130-142, 2001 | 156 | 2001 |